Suppr超能文献

携带抗原的未成熟树突状细胞在人体内可诱导体内肽特异性CD8(+)调节性T细胞。

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans.

作者信息

Dhodapkar Madhav V, Steinman Ralph M

机构信息

Laboratory of Tumor Immunology and Immunotherapy Rockefeller University; New York, NY 10021, USA.

出版信息

Blood. 2002 Jul 1;100(1):174-7. doi: 10.1182/blood.v100.1.174.

Abstract

Regulatory T cells (T(R)s) can suppress the function of other effector T cells in the setting of autoimmunity, transplantation, and resistance to tumors. The mechanism for the induction of T(R)s has not been defined. We previously reported that an injection of immature dendritic cells (DCs) pulsed with influenza matrix peptide (MP) led 7 days later to antigen-specific silencing of effector T-cell function in the blood of 2 healthy human subjects. Here, we found that interferon-gamma-producing effectors return by 6 months. Importantly, in mixing experiments, CD8(+) T cells from the sample obtained 7 days after injection could suppress MP-specific effectors obtained before injection and those in recovery samples. This suppression or regulation was specific for the immunizing peptide (MP) and cell-dose dependent, and it required contact between the 2 samples. These data show the capacity of immature DCs to induce antigen-specific regulatory CD8(+) T cells in humans.

摘要

调节性T细胞(T(R)s)在自身免疫、移植及肿瘤抵抗过程中能够抑制其他效应T细胞的功能。T(R)s的诱导机制尚未明确。我们之前报道过,注射用流感基质肽(MP)脉冲处理过的未成熟树突状细胞(DCs),7天后可导致2名健康人体血液中效应T细胞功能的抗原特异性沉默。在此,我们发现产生干扰素-γ的效应细胞在6个月后恢复。重要的是,在混合实验中,注射后7天所取样本中的CD8(+) T细胞能够抑制注射前获取样本及恢复样本中的MP特异性效应细胞。这种抑制或调节作用对免疫肽(MP)具有特异性且依赖细胞剂量,并且需要两个样本之间的接触。这些数据表明未成熟DCs在人体内诱导抗原特异性调节性CD8(+) T细胞的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验